Optimization of virtual reality for pain management of percutaneous transhepatic biliary drainage

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006775

Enrollment

Registered

2021-11-22

Start date

2021-12-09

Completion date

Unknown

Last updated

2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : VR therapy is applied to both groups and divided into breathing induction and without breathing. The VR therapy is 7 minutes long in all groups, and the content is mainly about enjoyi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 19 years of age or older undergoing PTBD who voluntarily consented in writing to participate in this study using VR therapy

Exclusion criteria

Exclusion criteria: Patients with cognitive decline, vision (including color recognition) or hearing loss, or facial defects, injuries or malformations, brain damage, or brain metastases that are not suitable for VR application

Design outcomes

Primary

Measure	Time frame
Analgesic dosage (mean total milligrams of morphine equivalent, MME) and patient's subjective pain scale assessed by numeric rating scale (NRS)	—

Secondary

Measure	Time frame
Changes in total bilirubin levels before and after PTBD	—

Countries

Korea, Republic of

Contacts

Public ContactMoonho Kim

University of Ulsan

muno0802@hanmail.net+82-33-610-4265

Outcome results